National Vision (NASDAQ:EYE – Free Report) had its target price lifted by UBS Group from $30.00 to $32.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has a buy rating on the stock.
Several other analysts have also recently commented on the company. Wells Fargo & Company set a $27.00 target price on National Vision and gave the company an “equal weight” rating in a report on Thursday, August 7th. Barclays dropped their price objective on National Vision from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Thursday, August 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of National Vision in a research note on Wednesday, October 8th. Roth Capital assumed coverage on National Vision in a report on Wednesday, July 30th. They issued a “buy” rating and a $36.00 target price for the company. Finally, The Goldman Sachs Group increased their target price on shares of National Vision from $17.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, August 7th. Six analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $24.91.
Check Out Our Latest Stock Analysis on EYE
National Vision Trading Up 2.8%
National Vision (NASDAQ:EYE – Get Free Report) last announced its earnings results on Wednesday, November 5th. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.12 by $0.01. National Vision had a positive return on equity of 3.58% and a negative net margin of 0.12%.The firm had revenue of $487.33 million for the quarter, compared to the consensus estimate of $472.98 million. During the same period in the previous year, the business earned $0.12 EPS. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. National Vision has set its FY 2025 guidance at 0.620-0.700 EPS. Equities research analysts anticipate that National Vision will post 0.31 EPS for the current fiscal year.
Insider Activity
In related news, Chairman L Reade Fahs sold 137,400 shares of the stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of $24.33, for a total transaction of $3,342,942.00. Following the completion of the sale, the chairman directly owned 544,795 shares of the company’s stock, valued at approximately $13,254,862.35. This trade represents a 20.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.70% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On National Vision
Hedge funds have recently made changes to their positions in the business. Geneos Wealth Management Inc. bought a new position in National Vision during the third quarter valued at about $29,000. Elevation Point Wealth Partners LLC purchased a new position in National Vision in the second quarter valued at approximately $35,000. Meeder Asset Management Inc. bought a new position in National Vision during the first quarter valued at $35,000. Smartleaf Asset Management LLC grew its holdings in National Vision by 69.3% during the first quarter. Smartleaf Asset Management LLC now owns 3,004 shares of the company’s stock valued at $39,000 after purchasing an additional 1,230 shares during the period. Finally, LSV Asset Management purchased a new stake in National Vision in the third quarter worth $93,000.
About National Vision
National Vision Holdings, Inc, through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America’s Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services.
Further Reading
- Five stocks we like better than National Vision
- How to Buy Gold Stock and Invest in Gold
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- 3 Healthcare Dividend Stocks to Buy
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for National Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Vision and related companies with MarketBeat.com's FREE daily email newsletter.
